158 related articles for article (PubMed ID: 2557043)
1. Inhibition of xanthine oxidase by 4-hydroxy-6-mercaptopyrazolo[3,4-d]pyrimidine.
Spector T; Hall WW; Porter DJ; Lambe CU; Nelson DJ; Krenitsky TA
Biochem Pharmacol; 1989 Dec; 38(23):4315-20. PubMed ID: 2557043
[TBL] [Abstract][Full Text] [Related]
2. Oxypurinol as an inhibitor of xanthine oxidase-catalyzed production of superoxide radical.
Spector T
Biochem Pharmacol; 1988 Jan; 37(2):349-52. PubMed ID: 2829916
[TBL] [Abstract][Full Text] [Related]
3. On the specificity of allopurinol and oxypurinol as inhibitors of xanthine oxidase. A pulse radiolysis determination of rate constants for reaction of allopurinol and oxypurinol with hydroxyl radicals.
Hoey BM; Butler J; Halliwell B
Free Radic Res Commun; 1988; 4(4):259-63. PubMed ID: 2852627
[TBL] [Abstract][Full Text] [Related]
4. Binding of xanthine oxidase to glycosaminoglycans limits inhibition by oxypurinol.
Kelley EE; Trostchansky A; Rubbo H; Freeman BA; Radi R; Tarpey MM
J Biol Chem; 2004 Sep; 279(36):37231-4. PubMed ID: 15231841
[TBL] [Abstract][Full Text] [Related]
5. Role of xanthine oxidase inhibitor as free radical scavenger: a novel mechanism of action of allopurinol and oxypurinol in myocardial salvage.
Das DK; Engelman RM; Clement R; Otani H; Prasad MR; Rao PS
Biochem Biophys Res Commun; 1987 Oct; 148(1):314-9. PubMed ID: 2823807
[TBL] [Abstract][Full Text] [Related]
6. Human and bovine xanthine oxidases. Inhibition studies with oxipurinol.
Spector T; Hall WW; Krenitsky TA
Biochem Pharmacol; 1986 Sep; 35(18):3109-14. PubMed ID: 3755906
[TBL] [Abstract][Full Text] [Related]
7. Kinetic and e.p.r. studies on the inhibition of xanthine oxidase by alloxanthine (1 H-pyrazolo [3, 4-d] pyrimidine-4,6-diol).
Williams JW; Bray RC
Biochem J; 1981 Jun; 195(3):753-60. PubMed ID: 6274312
[TBL] [Abstract][Full Text] [Related]
8. Xanthine oxidase inhibition does not limit canine infarct size.
Werns SW; Grum CM; Ventura A; Hahn RA; Ho PP; Towner RD; Fantone JC; Schork MA; Lucchesi BR
Circulation; 1991 Mar; 83(3):995-1005. PubMed ID: 1999047
[TBL] [Abstract][Full Text] [Related]
9. Substrate inhibition of xanthine oxidase and its influence on superoxide radical production.
Rubbo H; Radi R; Prodanov E
Biochim Biophys Acta; 1991 Aug; 1074(3):386-91. PubMed ID: 1653611
[TBL] [Abstract][Full Text] [Related]
10. Superoxide radical production by allopurinol and xanthine oxidase.
Galbusera C; Orth P; Fedida D; Spector T
Biochem Pharmacol; 2006 Jun; 71(12):1747-52. PubMed ID: 16650385
[TBL] [Abstract][Full Text] [Related]
11. Biochemical characterization of some pyrazolopyrimidine-based inhibitors of xanthine oxidase.
Tamta H; Kalra S; Mukhopadhyay AK
Biochemistry (Mosc); 2006; 71 Suppl 1():S49-54. PubMed ID: 16487068
[TBL] [Abstract][Full Text] [Related]
12. Oxypurinol, a xanthine oxidase inhibitor and a superoxide scavenger, did not attenuate ischemic neuronal damage in gerbils.
Arai T; Mori H; Ishii H; Adachi T; Endo N; Makino K; Mori K
Life Sci; 1998; 63(7):PL 107-12. PubMed ID: 9718087
[TBL] [Abstract][Full Text] [Related]
13. The pharmacokinetics of injectable allopurinol in newborns with the hypoplastic left heart syndrome.
McGaurn SP; Davis LE; Krawczeniuk MM; Murphy JD; Jacobs ML; Norwood WI; Clancy RR
Pediatrics; 1994 Dec; 94(6 Pt 1):820-3. PubMed ID: 7970996
[TBL] [Abstract][Full Text] [Related]
14. Effects of xanthine oxidase inhibition on ischemic acute renal failure in the rat.
Zager RA; Gmur DJ
Am J Physiol; 1989 Dec; 257(6 Pt 2):F953-8. PubMed ID: 2603962
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of xanthine oxidase improves myocardial contractility in patients with ischemic cardiomyopathy.
Baldus S; Müllerleile K; Chumley P; Steven D; Rudolph V; Lund GK; Staude HJ; Stork A; Köster R; Kähler J; Weiss C; Münzel T; Meinertz T; Freeman BA; Heitzer T
Free Radic Biol Med; 2006 Oct; 41(8):1282-8. PubMed ID: 17015175
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of xanthine oxidase by uric acid and its influence on superoxide radical production.
Radi R; Tan S; Prodanov E; Evans RA; Parks DA
Biochim Biophys Acta; 1992 Jul; 1122(2):178-82. PubMed ID: 1322703
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms of protection of hepatocytes at anoxia and reoxygenation by the xanthine oxidase inhibitor oxypurinol.
Schneider W; Siems WG; Grune T; Schneider C; Gerber G
Adv Exp Med Biol; 1991; 309A():339-42. PubMed ID: 1789238
[No Abstract] [Full Text] [Related]
18. Pharmacokinetic/Pharmacodynamic Modelling of Allopurinol, its Active Metabolite Oxypurinol, and Biomarkers Hypoxanthine, Xanthine and Uric Acid in Hypoxic-Ischemic Encephalopathy Neonates.
Chu WY; Annink KV; Nijstad AL; Maiwald CA; Schroth M; Bakkali LE; van Bel F; Benders MJNL; van Weissenbruch MM; Hagen A; Franz AR; Dorlo TPC; Allegaert K; Huitema ADR;
Clin Pharmacokinet; 2022 Feb; 61(2):321-333. PubMed ID: 34617261
[TBL] [Abstract][Full Text] [Related]
19. Tissue protective effect of xanthine oxidase inhibitor, polymer conjugate of (styrene-maleic acid copolymer) and (4-amino-6-hydroxypyrazolo[3,4-d]pyrimidine), on hepatic ischemia-reperfusion injury.
Fang J; Seki T; Qin H; Bharate GY; Iyer AK; Maeda H
Exp Biol Med (Maywood); 2010 Apr; 235(4):487-96. PubMed ID: 20407081
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of xanthine oxidase by synthetic cytokinin analogues.
Sheu SY; Lin YC; Chiang HC
Anticancer Res; 1997; 17(2A):1043-9. PubMed ID: 9137447
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
